Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics Document date: 2020_4_14
ID: fnrm6a79_18
Snippet: A similar pattern can be seen for the non-industry-sponsored vaccine development programs; excluding the 'others' category, the top three most researched vaccine categories are also respiratory infections (24.8%), HIV (20.4%), and HBV (8.2%), whereas Middle East Respiratory Syndrome (MERS) and SARS are the least researched diseases with one development program each. CC-BY 4.0 International license It is made available under a author/funder, who h.....
Document: A similar pattern can be seen for the non-industry-sponsored vaccine development programs; excluding the 'others' category, the top three most researched vaccine categories are also respiratory infections (24.8%), HIV (20.4%), and HBV (8.2%), whereas Middle East Respiratory Syndrome (MERS) and SARS are the least researched diseases with one development program each. CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- development program and respiratory infection: 1, 2, 3
- development program and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- development program and vaccine development program: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- industry sponsor and researched vaccine category: 1
- industry sponsor and vaccine category: 1
- industry sponsor and vaccine development: 1
- international license and research disease: 1, 2
- international license and respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- international license and similar pattern: 1, 2, 3, 4, 5, 6, 7
- international license and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- research disease and respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- research disease and vaccine category: 1, 2
- research disease and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- researched vaccine category and vaccine category: 1
- researched vaccine category and vaccine development: 1
- respiratory infection and similar pattern: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- respiratory infection and vaccine category: 1, 2
- respiratory infection and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- similar pattern and vaccine development: 1, 2
Co phrase search for related documents, hyperlinks ordered by date